UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Annals of oncology, 2006-06, Vol.17 (6), p.935-944

2006

Volltextzugriff (PDF)

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Breast (Edinburgh), 2012-02, Vol.21 (1), p.20-26

2012

Volltextzugriff (PDF)

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

European journal of cancer (1990), 2015-09, Vol.51, p.S313-S313

2015

Volltextzugriff (PDF)

A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting

British journal of dermatology (1951), 2015-12, Vol.173 (6), p.1462-1470

2015

Volltextzugriff (PDF)

Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis

American journal of transplantation, 2006-11, Vol.6 (11), p.2644-2650

2006

Volltextzugriff (PDF)

Brain metastases and subtypes of breast cancer

Annals of oncology, 2009-05, Vol.20 (5), p.803-805

Pestalozzi, B.C.

2009

Volltextzugriff (PDF)

First evidence of antitumor activity of ITPP, a novel hypoxia-modifier: Results of a phase Ib trial

Annals of oncology, 2018-12, Vol.29, p.x35-x35

2018

Volltextzugriff (PDF)

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Annals of oncology, 2009-09, Vol.20 (9), p.1522-1528

2009

Volltextzugriff (PDF)

Infiltrating lobular carcinoma of the breast: systemic treatment

Breast disease, 2008, Vol.30 (1), p.45-52

2008

Volltextzugriff (PDF)

Clinical presentation and surgical management of invasive lobular carcinoma of the breast

Breast disease, 2008, Vol.30 (1), p.31-37

2008

Volltextzugriff (PDF)

Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls

Breast disease, 2008, Vol.30 (1), p.15-19

2008

Volltextzugriff (PDF)

Editorial

Breast disease, 2009-09, Vol.30 (1), p.1-1

2009

Volltextzugriff (PDF)

Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors

British journal of dermatology (1951), 2016-02, Vol.174 (2), p.463-463

2016

Volltextzugriff (PDF)

Hormone replacement therapy and the increase in the incidence of invasive lobular cancer

Breast disease, 2008, Vol.30 (1), p.3-8

2008

Volltextzugriff (PDF)

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer

Annals of oncology, 2016-10, Vol.27, p.vi231-vi231

2016

Volltextzugriff (PDF)

Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer

Annals of oncology, 2016-10, Vol.27, p.vi548-vi548

2016

Volltextzugriff (PDF)

Trastuzumab beyond progression: a cost-utility analysis

Annals of oncology, 2010-11, Vol.21 (11), p.2161-2168

2010

Volltextzugriff (PDF)

Distinct clinical and prognostic features of invasive lobular breast cancer

Breast disease, 2008, Vol.30 (1), p.39-44

2008

Volltextzugriff (PDF)

Relapse of invasive lobular carcinoma

Breast disease, 2008, Vol.30 (1), p.53-56

2008

Volltextzugriff (PDF)

Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)

European journal of cancer care, 2017-07, Vol.26 (4), p.e12453-n/a

2017

Volltextzugriff (PDF)

Molecular pathology of invasive lobular breast carcinoma

Breast disease, 2008, Vol.30 (1), p.9-14

2008

Volltextzugriff (PDF)

Infiltrating lobular carcinoma: four case illustrations

Breast disease, 2008, Vol.30 (1), p.57-61

2008

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i7-i9

2005

Volltextzugriff (PDF)

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Annals of oncology, 2008-11, Vol.19 (11), p.1837-1841

2008

Volltextzugriff (PDF)

Feasibility of Using Cetuximab and Bevacizumab in a Patient with Colorectal Cancer and Terminal Renal Failure

Oncology, 2007-01, Vol.72 (3-4), p.209-210

2007

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Female
(19)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Oncology
(12)
Biological And Medical Sciences
(8)
Middle Aged
(8)
Breast Neoplasms - Pathology
(7)
Medical Sciences
(7)
Aged
(5)
Breast Neoplasms - Drug Therapy
(5)
Tumors
(5)
Adult
(4)
Antineoplastic Agents
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Neoplasms - Diagnosis
(4)
Neoplasm Metastasis
(4)
Pharmacology. Drug Treatments
(4)
Breast Cancer
(3)
Breast Neoplasms - Mortality
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting

Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis

Brain metastases and subtypes of breast cancer

First evidence of antitumor activity of ITPP, a novel hypoxia-modifier: Results of a phase Ib trial

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Infiltrating lobular carcinoma of the breast: systemic treatment

Clinical presentation and surgical management of invasive lobular carcinoma of the breast

Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls

Editorial

Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors

Hormone replacement therapy and the increase in the incidence of invasive lobular cancer

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer

Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer

Trastuzumab beyond progression: a cost-utility analysis

Distinct clinical and prognostic features of invasive lobular breast cancer

Relapse of invasive lobular carcinoma

Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)

Molecular pathology of invasive lobular breast carcinoma

Infiltrating lobular carcinoma: four case illustrations

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Feasibility of Using Cetuximab and Bevacizumab in a Patient with Colorectal Cancer and Terminal Renal Failure

Suchergebnisse filtern